INmune Bio, Inc.

INMBNASDAQHealthcare● Active

$1.29

+$0.05(+3.63%)

Market Cap$34162057

P/E Ratio—

52W High$11.64

52W Low$1.09

Avg Volume436K

Open$1.26

Beta1.01

Overview

INmune Bio, Inc. (INMB) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · INMB · as of Mar 30, 2026

Latest filing snapshot

+8+61.54%vs prior year

INmune Bio, Inc. (INMB) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+61.54%

Revenue / Employee

$2.4K

Net Income / Employee

$-2.19M

Market Cap

$33M

INMB Employee Count

2018 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-30	2025-12-31	21	+8	+61.54%
2025-03-27	2024-12-31	13	+2	+18.18%
2024-03-28	2023-12-31	11	+1	+10.00%
2023-03-02	2022-12-31	10	+0	+0.00%
2022-03-03	2021-12-31	10	+5	+100.00%
2021-03-04	2020-12-31	5	+1	+25.00%
2020-03-11	2019-12-31	4	+1	+33.33%
2019-03-29	2018-12-31	3	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Barinthus Biotherapeutics plc

105$29M #3

MRSN

Mersana Therapeutics, Inc.

102$145M #4

ALGS

Aligos Therapeutics, Inc.

70$31M #5

OKUR

OnKure Therapeutics, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · INMB peer comparison

About INMB employees

INMB Employees · Headcount

INmune Bio, Inc. (INMB) employee data is sourced from the annual SEC 10-K filing. As of 2025, INmune Bio, Inc. had 21 full-time employees globally. Full-time employees only. Global consolidated headcount.

INmune Bio, Inc. employs 21 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $2,381, reflecting the company's operational efficiency.

INmune Bio, Inc.'s workforce increased by 8 (61.54%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

INmune Bio, Inc.'s revenue per employee of $2,381 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

INMB Employees · 5 questions

As of the latest SEC 10-K filing (2025), INmune Bio, Inc. had 21 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

INmune Bio, Inc. employee counthow many employees does INmune Bio, Inc. haveINMB total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-30